Verteporfiinihoidon
Verteporfiinihoidon, often referred to as photodynamic therapy (PDT) with verteporfin, is a medical treatment used primarily for certain eye conditions. The active component, verteporfin, is a light-sensitive drug. It is administered intravenously and selectively accumulates in rapidly growing cells, such as those found in abnormal blood vessels in the eye.
Once the verteporfin has circulated and accumulated, the targeted area of the eye is illuminated with a
The primary indication for verteporfin PDT is the treatment of wet age-related macular degeneration (AMD). In